Pharming Group NV Net Asset Momentum
Pharming Group NV net asset momentum. Pharming Group NV (PHARM) recorded a net asset momentum of 8.1% as of December 2024, with net assets of €214.16 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Pharming Group NV (PHARM) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Pharming Group NV (2005–2024)
Net asset momentum of Pharming Group NV from 2005 to 2024. This chart tracks Pharming Group NV's year-over-year net asset growth across 20 annual reporting periods from 2005 to 2024. The most recent momentum reading is +8.1%, with net assets of €214.16 Million EUR as of December 2024. See Pharming Group NV (PHARM) shareholders funds for net asset value and shareholders' equity analysis.
Pharming Group NV Net Asset Momentum by Year (2005–2024)
Pharming Group NV net asset momentum by year from 2005 to 2024. The table below shows the complete annual net asset history for Pharming Group NV from 2005 to 2024, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Pharming Group NV (PHARM) market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €214.16 Million | €386.88 Million | €172.72 Million | ▲ +8.1% |
| 2023 | €198.05 Million | €426.34 Million | €228.28 Million | ▼ -3.2% |
| 2022 | €204.64 Million | €425.80 Million | €221.16 Million | ▲ +6.2% |
| 2021 | €192.72 Million | €396.90 Million | €204.19 Million | ▲ +4.9% |
| 2020 | €183.73 Million | €419.12 Million | €235.39 Million | ▲ +56.7% |
| 2019 | €117.26 Million | €255.63 Million | €138.38 Million | ▲ +66.0% |
| 2018 | €70.64 Million | €245.45 Million | €174.81 Million | ▲ +213.2% |
| 2017 | €22.56 Million | €199.38 Million | €176.82 Million | ▼ -21.9% |
| 2016 | €28.89 Million | €133.34 Million | €104.45 Million | ▲ +10.8% |
| 2015 | €26.06 Million | €63.06 Million | €37.00 Million | ▼ -28.2% |
| 2014 | €36.29 Million | €67.75 Million | €31.46 Million | ▲ +424.6% |
| 2013 | €6.92 Million | €43.37 Million | €36.45 Million | ▲ +168.4% |
| 2012 | €-10.12 Million | €22.28 Million | €32.40 Million | ▼ -557.2% |
| 2011 | €-1.54 Million | €32.01 Million | €33.55 Million | ▼ -111.5% |
| 2010 | €13.43 Million | €49.59 Million | €36.16 Million | ▼ -29.6% |
| 2009 | €19.07 Million | €80.07 Million | €60.99 Million | ▲ +9.3% |
| 2008 | €17.45 Million | €93.40 Million | €75.96 Million | ▼ -65.5% |
| 2007 | €50.58 Million | €166.72 Million | €116.14 Million | ▼ -23.1% |
| 2006 | €65.78 Million | €104.37 Million | €38.59 Million | ▲ +93.3% |
| 2005 | €34.04 Million | €40.96 Million | €6.93 Million | — |